SCHEMBL6713639

SCHEMBL6713639

CCCOc1ccccc1C(=O)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.42
MAPT P10636 3/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
KCNMA1 Q12791 1/20 0.42
POLB P06746 3/20 0.41
LMNA P02545 2/20 0.41
PNLIP P16233 1/20 0.41
LCLAT1 Q6UWP7 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GBA1 P04062 1/20 0.39
AKR1C3 P42330 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
MRGPRX1 Q96LB2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921771 0.92 MAPT (0.40) TP53MAPTTSHRMEN1KMT2A
SCHEMBL6711397 0.91 TP53 (0.41) TP53MAPTMEN1KMT2AGAA
SCHEMBL6713914 0.89 RXFP1 (0.44) TP53MAPTTSHRMEN1KMT2A
SCHEMBL6710588 0.86 TP53 (0.43) TP53MAPTTSHRMEN1KMT2A
SCHEMBL6710253 0.86 TP53 (0.43) TP53MAPTMEN1KMT2APOLB
SCHEMBL6712036 0.85 KCNMA1 (0.45) MEN1KMT2AKCNMA1ALDH1A1HTT
SCHEMBL6712433 0.84 GRIK1 (0.42) TP53MAPTMEN1KMT2AGAA
SCHEMBL6709877 0.84 GRIK1 (0.43) TP53MAPTMEN1KMT2AALOX15
SCHEMBL6712018 0.84 CHRNB2 (0.42) MAPTPOLBGRIK1
SCHEMBL6709173 0.83 GRIK1 (0.44) TP53MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 TP53 2699/4885MAPT 4754/4885TSHR 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.